65% of retailers cite conversion optimization as the #1 ecommerce challenge
Mollie reveals the state of payments across retail in Europe Amsterdam and London, 11 March…
Mollie reveals the state of payments across retail in Europe Amsterdam and London, 11 March…
The REMDACTA clinical trial of Actemra/RoActemra plus Veklury did not meet its primary endpoint of…
For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the…
JSC Olainfarm has been invited to participate in building a vaccine manufacturing plant in Latvia…
Phase 3 data comparing tebentafusp (IMCgp100) with investigator’s choice subject of oral plenary OXFORDSHIRE, England…
– Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85%…
Legally required documents for shareholders’ votes are available on Biophytis website PARIS and CAMBRIDGE, Mass.,…
Strong cash and cash equivalents position at Dec 31, 2020 of $20.2M (CHF18.7M) Balance sheet…
SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
GUANGZHOU, China, March 10, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
CBL-B inhibitor NX-1607 mediates anti-tumor activity through both T cells and NK cellsPreclinical tumor models…
AFM24 preclinical in vivo data will be presented as a poster Data on AFM13 in…
SAN CARLOS, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Media Release Copenhagen, Denmark, March 10, 2021 ·Two posters featuring innovative Genmab bispecific antibody programs…
SEATTLE, March 10, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company revolutionizing…
ZUG, Switzerland and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
— Two presentations to highlight AO-176’s potential in lymphoma and T-ALL — BRISBANE, Calif. and ST….
– Healthy volunteer clinical data for exoIL-12 accepted as a late-breaking abstract – – Preclinical data…
WATERTOWN, Mass., March 10, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…